Ambulatory Transition from Parenteral Prostanoid to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension

被引：0
|
作者：
Lucas M. Kimmig
Chuanhong Liao
Remzi Bag
机构：
[1] The University of Chicago Medicine,Section of Pulmonary and Critical Care Medicine
[2] The University of Chicago,Department of Public Health Sciences
[3] The University of Chicago,Biological Sciences Division
来源：
Lung | 2020年 / 198卷
关键词：
Pulmonary arterial hypertension; Prostacyclins; Prostanoids; Inhaled prostanoids; Transition;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：53 / 58
页数：5
相关论文
共 50 条
  • [41] Transition From Oral Treprostinil to Selexipag in a Patient With Pulmonary Arterial Hypertension
    Verlinden, Nathan J.
    Walter, Claire
    Kanwar, Manreet
    Raina, Amresh
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (07) : 764 - 765
  • [42] Transition from epoprostenol to treprostinil in pulmonary arterial hypertension: A controlled trial
    Rubenfire, Melvyn
    McLaughlin, Vallerie
    Allen, Roblee
    Elliott, Gregory
    Park, Myung
    Wade, Michael
    Schilz, Robert J.
    CHEST, 2006, 130 (04) : 258S - 258S
  • [43] TRANSITION FROM SELEXIPAG TO ORAL TREPROSTINIL IN A PATIENT WITH PULMONARY ARTERIAL HYPERTENSION
    Patel, Amol
    Safdar, Zeenat
    CHEST, 2018, 154 (04) : 1023A - 1024A
  • [44] Transition from selexipag to oral treprostinil in a patient with pulmonary arterial hypertension
    Oriaku, Ifeoma
    Patel, Amol
    Safdar, Zeenat
    PULMONARY CIRCULATION, 2020, 10 (01)
  • [45] Transition from epoprostenol to treprostinil in pulmonary arterial hypertension: a controlled trial
    Schilz, R.
    Rubenfire, M.
    Mclaughlin, V.
    Allen, R.
    Elliott, G.
    Park, M.
    Wade, M.
    EUROPEAN HEART JOURNAL, 2006, 27 : 622 - 622
  • [46] Transitioning from parenteral to inhaled prostacyclin therapy in pulmonary arterial hypertension
    Ataya, Ali
    Somoracki, Angelina
    Cope, Jessica
    Alnuaimat, Hassan
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2016, 40 : 39 - 43
  • [47] Uncommon complication of pulmonary arterial hypertension treatment with the parenteral use of treprostinil
    Zielska, Malgorzata
    Lewandowski, Maciej
    Widecka, Katarzyna
    Kurzyna, Marcin
    Kedzierski, Piotr
    Dib, Naser
    Kazmierczak, Jaroslaw
    Peregud-Pogorzelska, Malgorzata
    KARDIOLOGIA POLSKA, 2021, 79 (01) : 79 - 80
  • [48] Oral Selexipag versus Inhaled Treprostinil Effect on Pulmonary Arterial Hypertension
    Nguyen, J. Q.
    Teklu, Y.
    Wu, S.
    Kolaitis, N. A.
    De Marco, T.
    Fanous, S. M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S427 - S427
  • [49] Effectiveness and Safety of Inhaled Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Children
    Krishnan, Usha
    Takatsuki, Shinichi
    Ivy, Dunbar D.
    Kerstein, Jason
    Calderbank, Michelle
    Coleman, Elizabeth
    Rosenzweig, Erika B.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (11): : 1704 - 1709
  • [50] Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension
    Keogh, Anne M.
    Jabbour, Andrew
    Weintraub, Robert
    Brown, Karen
    Hayward, Chris S.
    Macdonald, Peter S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (11): : 1079 - 1083
12345